Latest LEAD updates
What partnerships are needed to ramp up the development of low-cost antimicrobial drugs?
As antimicrobial resistance continues to outpace innovation, AMR exposes a fundamental market failure with global consequences. LEAD core team member and IDS Research Fellow, Professor Gerry Bloom, highlights that addressing it will require not just scientific breakthroughs, but it demands new forms of collaboration across governments, industry, funders and civil society. This is a global issue, and it needs global collaboration.
LEAD Fellows on Japan's global news
On 10 June 2025, the NHK World news channel and website broadcast a piece on collaboration between Japan and the UK to tackle AMR through the discovery and development of new antimicrobials.
It featured LEAD''s Professor Dame Sally Davies and Mr. Yasuhisa Shiozaki UK-Japan AMR Policy Fellows, Dr Alicia Demirjian, of the UK Health Security Agency, and Dr Nobuaki Matsunaga, of the Japan Institute for Health Security.
Dr Demirjian and Dr Matsunaga talk about the importance of new antimicrobials against the threat of AMR.